Assessing DMRs between treatment groups: subtracting control group DMRs to account for "baseline" methylation
2
0
Entering edit mode
5.2 years ago
Ellen O ▴ 20

I am currently awaiting Illumina methylationEPIC (850k) data and in the mean time figuring out how to assess DMRs with demo data. I am new to these analyses but I am making use of the Maksimovic et al. cross-package workflow (https://f1000research.com/articles/5-1281/v2), which I have found very useful thus far.

I have three sample groups: healthy controls, poor treatment responders, and good treatment responders. I was wondering if it is possible to "subtract" the differential methylation seen within the controls before comparing the two treatment groups, so that I can account for a baseline/ "normal" level of variable methylation. Would this be possible in limma, minfi or any other packages? Or would it make more sense to just compare all three groups to each other?

Thanks in advance for any assistance!

illumina 850k methylationEPIC DMR • 1.4k views
ADD COMMENT
0
Entering edit mode
5.2 years ago

Others may be able to correct me if I'm wrong... but if you're making a contrast matrix in Limma, you could just do something along the lines of:

(healthy_control - poor_response) - (healthy_control - good_response)
ADD COMMENT
0
Entering edit mode

Thanks Andrew, I will try it out!

ADD REPLY
0
Entering edit mode
4.9 years ago
hongbo919 ▴ 30

I suggest using the DMR identification software based on entropy such QDMR (for pre-defined regions) or SMART (for de novo identification of DMRs from BS-Seq data). As there are multiple samples in the same group, the DMC function of SMART should work for your project.

ADD COMMENT

Login before adding your answer.

Traffic: 1214 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6